Bartoccioni, Emanuela
 Distribuzione geografica
Continente #
NA - Nord America 1.833
EU - Europa 1.536
AS - Asia 362
AF - Africa 16
SA - Sud America 5
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.759
Nazione #
US - Stati Uniti d'America 1.822
PL - Polonia 310
DE - Germania 305
SE - Svezia 290
CN - Cina 238
IT - Italia 187
UA - Ucraina 141
IE - Irlanda 84
FR - Francia 80
GB - Regno Unito 48
SG - Singapore 41
IN - India 38
FI - Finlandia 35
BE - Belgio 16
HK - Hong Kong 14
TR - Turchia 13
CH - Svizzera 11
CA - Canada 10
CI - Costa d'Avorio 10
NL - Olanda 9
AU - Australia 4
IR - Iran 4
NO - Norvegia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BR - Brasile 3
CZ - Repubblica Ceca 3
ES - Italia 3
LK - Sri Lanka 3
VN - Vietnam 3
AL - Albania 2
GA - Gabon 2
IQ - Iraq 2
RO - Romania 2
RU - Federazione Russa 2
ZA - Sudafrica 2
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
EC - Ecuador 1
HU - Ungheria 1
JP - Giappone 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MX - Messico 1
PK - Pakistan 1
SA - Arabia Saudita 1
SC - Seychelles 1
TW - Taiwan 1
Totale 3.759
Città #
Chandler 394
Warsaw 284
Ashburn 231
Jacksonville 97
San Mateo 88
Dublin 82
Ann Arbor 64
Wilmington 61
Woodbridge 60
Cattolica 58
Nanjing 48
Bremen 47
Houston 47
Dearborn 44
Boston 34
Chicago 34
Fairfield 32
Redwood City 28
Milan 26
New York 26
Seattle 26
Singapore 25
Kraków 23
Lawrence 23
Princeton 23
Marseille 22
Beijing 19
Nanchang 17
Rome 15
Brussels 14
Izmir 13
Cambridge 12
Washington 11
Abidjan 10
Hong Kong 10
Lancaster 10
Mountain View 9
Norwalk 9
Nürnberg 9
Shenyang 9
Hebei 8
Tianjin 8
Zurich 8
Changsha 7
Chengdu 7
Hangzhou 7
University Park 7
Zhengzhou 7
Boardman 6
Genoa 6
Jiaxing 6
Helsinki 5
Shanghai 5
Busto Arsizio 4
Falls Church 4
London 4
Los Angeles 4
Oslo 4
Philadelphia 4
Renton 4
Baltimore 3
Changchun 3
Colombo 3
Edinburgh 3
Fuzhou 3
Gallup 3
Gunzenhausen 3
Hefei 3
Kunming 3
Lachine 3
Trieste 3
Amsterdam 2
Atlanta 2
Berlin 2
Bern 2
Brescia 2
Cascina 2
Changzhou 2
Clearwater 2
Dong Ket 2
Fremont 2
Gdynia 2
Guangzhou 2
Gurgaon 2
Indiana 2
Libreville 2
Melbourne 2
Millbury 2
Munich 2
Naples 2
Napoli 2
Ostrava 2
Perugia 2
Pune 2
Saint Paul 2
Salt Lake City 2
San Diego 2
San Francisco 2
Santa Clara 2
Scandicci 2
Totale 2.300
Nome #
Association of the DNMT3B -579G>T polymorphism with risk of thymomas in patients with myasthenia gravis 288
Age-Related Sarcopenia: Diabetes of the Muscle? 245
Novel path to IL-6 trans-signaling through thrombin-induced soluble IL-6 receptor release by platelets 147
Alterazioni delle risposte immuno-infiammatorie nei pazienti affetti da disturbo depressivo maggiore (Immune-inflammatory response changes in patients with major depressive disorder) 141
A Study of Inflammatory/Necrosis Biomarkers in the Fracture of the Femur Treated with Proximal Femoral Nail Antirotation 127
Poly-autoimmunity in patients with myasthenia gravis: A single-center experience 122
PTPN22 and myasthenia gravis: replication in an Italian population and meta-analysis of literature data 113
T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients 113
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 105
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 104
Low reliability of anti-KIR4.183-120 peptide auto-antibodies in multiple sclerosis patients 103
IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts. 98
Anti-AChR-negative myasthenia gravis: clinical and immunological features 96
Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis 95
Remission of myasthenia gravis with MuSK antibodies during ruxolitinib treatment 95
A Genome-wide Association Study of Myasthenia Gravis 94
HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5. 85
SNRI effective treatment does not restore changes of immune and inflammatory parameters in depressed patients 84
Test domiciliare per la diagnosi integrata di infezione da SARS-CoV-2 81
Response to therapy in myasthenia gravis with anti-MuSK antibody 80
Management challenges in muscle-specific tyrosine kinase myasthenia gravis. 79
Characterization of B cells in muscle-specific kinase antibody myasthenia gravis 78
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 78
BAFF serum levels in myasthenia gravis: effects of therapy 77
Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis. 76
Skeletal muscle cells: from local inflammatory response to active immunity 74
Rituximab in myasthenia gravis: a "to be or not to be" inhibitor of T cell function 68
Pattern of ocular involvement in myasthenia gravis with MuSK antibodies 66
Myasthenia gravis with antibodies to MuSK: an update 66
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 63
Low reliability of anti-KIR4.183–120peptide auto-antibodies in multiple sclerosis patients 60
Early-onset myasthenia gravis: clinical characteristics and response to therapy 57
Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravis 55
Myasthenia gravis and associated autoimmune diseases 52
Anti-P110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement 52
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis 52
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 51
IL-6, monocyte infiltration and parenchymal cells 50
Anti-MuSK antibodies: Correlation with myasthenia gravis severity 44
Identification of disease-specific autoantibodies in seronegative myasthenia gravis 42
Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus 40
Why Does an I.M. Immunization Work? 36
Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes 35
Immune-inflammatory response changes in patients with major depressive disorder 25
Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts 22
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 16
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 16
Totale 3.846
Categoria #
all - tutte 13.235
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.235


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201919 0 0 0 0 0 0 0 0 0 0 0 19
2019/2020452 84 22 32 30 30 22 77 15 22 17 70 31
2020/2021373 40 38 3 36 79 22 34 9 45 10 47 10
2021/2022461 34 35 11 20 46 11 12 78 21 26 76 91
2022/20231.083 148 140 66 201 64 121 41 104 124 31 30 13
2023/2024563 16 134 24 43 32 78 37 50 10 20 68 51
Totale 3.846